Navigation Links
A potentially life-saving protein takes shape
Date:7/2/2013

COLLEGE PARK, MD - A tiny protein called ubiquitin so named because it is present in every cell of living things as dissimilar as hollyhocks and humans - may hold the key to treatment for a variety of diseases from Parkinson's to diabetes. The protein, found in all eukaryotes (organisms with membranous cells), was considered unimportant when it was described in 1975. But scientists now know ubiquitin takes many different forms and is important in basic cellular processes, from controlling cells' circadian clocks to clearing away the harmful build-up of cells found in cancer and other diseases.

To maximize ubiquitin's potential for treating diseases, researchers are working to identify the protein's dizzying array of structures, and to understand each form's function. Ubiquitin forms polymeric chains linked by specific amino acids. Each ubiquitin protein can connect to its neighbor through one of eight different amino acids, and each combination appears to do something different in a normal cell, says University of Maryland structural biologist David Fushman, whose lab studies these ubiquitin chains and their linkages.

Imagine the cell as a dance floor, thronged with proteins seeking partners, says Fushman, who has studied ubiquitin since 2000. When two ubiquitins join through a lysine, "it's like two hands meeting, but with just a single finger touching that's specific to that lysine." The choice of lysine determines the shape of the ubiquitin chain, and probably also determines its function.

Fushman and his colleagues' newly published research focuses on one of the most common and least studied linkages, the polymeric chain formed by the amino acid Lysine-11. The ubiquitin chains linked by Lysine-11 "are directly involved in cell cycle regulation," Fushman says. To turn that knowledge into medically useful information, "we have to understand exactly how they form and with whom they interact."

Most work of this type is done in a test tube and uses x-ray crystallography to map the structures. Fushman's lab uses a different method that he says produces an environment somewhat closer to nature. The team used nuclear magnetic resonance spectroscopy (NMR) and other techniques to map the Lysine-11-linked chains.

The researchers found these chains take on a different shape in solution than in crystals, and are more flexible than was previously thought. Ubiquitin chains linked via Lysine-11 can form various three-dimensional shapes, and as salt concentrations change, the chains' shape also changes, the team found.

Researcher Carlos Castaeda and others in the Fushman lab reported their results in a paper published July 2 in the biological journal Structure.

The most-studied ubiquitin chain, linked via Lysine-48, is known as a "protein destroyer" because it labels cellular proteins to be broken up for later recycling. The UMD team found the cellular receptors responsible for breaking down proteins interact with Lysine-11 chains, but not as efficiently as with Lysine-48 chains. Therefore protein destruction does not appear to be the main task of the Lysine-11 linked chain, Fushman says; its function is something different and perhaps equally vital to maintaining healthy cells.


'/>"/>

Contact: Heather Dewar
hdewar@umd.edu
301-405-9267
University of Maryland
Source:Eurekalert

Related medicine news :

1. Potentially life-saving cooling treatment rarely used for in-hospital cardiac arrests
2. Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency And CIDP Potentially Supplemented by Approval for Alzheimers Disease Available at ResearchMoz.us
3. Artificial Ovaries Could Potentially Deliver Hormone Therapy
4. Office workers carry biomarker of potentially harmful flame retardant, study finds
5. Millions of people in Asia potentially exposed to health risks of popular herbal medicines
6. Brain stent offers alternative to shunt for fixing potentially blinding vein narrowing
7. 1 in 4 colonoscopies in Medicare patients found to be potentially inappropriate
8. High-throughput sequencing shows potentially hundreds of gene mutations related to autism
9. Robotic-assisted radical bladder surgery potentially benefits bladder cancer patients
10. Many home couches contain potentially toxic flame retardants
11. ACA: More than a million women could gain access to potentially life saving tests for cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: